1 Min Read
Dec 20 (Reuters) - Chiome Bioscience Inc :
* Says it to receive patent in New Zealand for ANTI-HUMAN TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO
Source text in Japanese: goo.gl/RqXNRJ
Further company Coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.